Pharmazon HomeCare

Mounjaro for Weight Management and Type 2 Diabetes

Mounjaro (tirzepatide) is indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. It is also approved for the treatment of adults with type 2 diabetes mellitus to improve glycemic control, alongside diet and exercise.

Mounjaro is a once-weekly injection that mimics the action of both GLP-1 and GIP hormones, helping to regulate appetite, glucose levels, and food intake, resulting in significant weight loss.

Scroll to Top
Contact Us
Contact Form Demo